Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 9 | 2024 | 508 | 3.510 |
Why?
|
| Monitoring, Intraoperative | 3 | 2024 | 116 | 1.430 |
Why?
|
| Echocardiography, Transesophageal | 6 | 2024 | 266 | 1.420 |
Why?
|
| Analgesia | 2 | 2022 | 65 | 1.380 |
Why?
|
| Tissue Donors | 2 | 2025 | 581 | 1.320 |
Why?
|
| Tissue and Organ Procurement | 2 | 2025 | 423 | 1.210 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 396 | 1.100 |
Why?
|
| Heart Transplantation | 2 | 2025 | 873 | 1.090 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 372 | 1.060 |
Why?
|
| Organ Preservation | 2 | 2025 | 139 | 1.030 |
Why?
|
| Postoperative Complications | 7 | 2024 | 2680 | 0.970 |
Why?
|
| Hypotension | 2 | 2017 | 80 | 0.850 |
Why?
|
| Vascular Resistance | 1 | 2024 | 98 | 0.850 |
Why?
|
| Perfusion | 1 | 2025 | 271 | 0.820 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 387 | 0.780 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2024 | 238 | 0.770 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2022 | 14 | 0.750 |
Why?
|
| Coronary Artery Bypass | 3 | 2022 | 231 | 0.740 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2022 | 309 | 0.740 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 161 | 0.700 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 103 | 0.700 |
Why?
|
| Kidney Diseases | 2 | 2022 | 314 | 0.680 |
Why?
|
| Morphine | 1 | 2021 | 127 | 0.650 |
Why?
|
| Medicine | 1 | 2021 | 95 | 0.620 |
Why?
|
| Kidney | 1 | 2024 | 1123 | 0.600 |
Why?
|
| Hospital Rapid Response Team | 1 | 2019 | 29 | 0.600 |
Why?
|
| Mitral Valve | 4 | 2021 | 229 | 0.580 |
Why?
|
| Marriage | 1 | 2019 | 23 | 0.580 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 411 | 0.570 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 1 | 2019 | 42 | 0.550 |
Why?
|
| Humans | 37 | 2025 | 98135 | 0.540 |
Why?
|
| Wireless Technology | 1 | 2018 | 21 | 0.540 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 148 | 0.520 |
Why?
|
| Cystectomy | 1 | 2018 | 124 | 0.510 |
Why?
|
| Myocardium | 2 | 2022 | 578 | 0.510 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2017 | 21 | 0.500 |
Why?
|
| Heart-Assist Devices | 4 | 2022 | 916 | 0.500 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 116 | 0.500 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 539 | 0.490 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1235 | 0.450 |
Why?
|
| Mitochondria | 1 | 2019 | 650 | 0.440 |
Why?
|
| Death | 2 | 2025 | 98 | 0.410 |
Why?
|
| Aortic Valve | 4 | 2022 | 258 | 0.410 |
Why?
|
| Endoscopy | 2 | 2022 | 384 | 0.410 |
Why?
|
| Angiotensins | 1 | 2013 | 6 | 0.390 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 403 | 0.390 |
Why?
|
| Graft Rejection | 1 | 2018 | 1186 | 0.370 |
Why?
|
| Heparin | 1 | 2013 | 182 | 0.370 |
Why?
|
| Lung Transplantation | 1 | 2017 | 390 | 0.350 |
Why?
|
| Elective Surgical Procedures | 1 | 2013 | 171 | 0.340 |
Why?
|
| Preoperative Care | 1 | 2013 | 418 | 0.320 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 111 | 0.320 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2011 | 121 | 0.310 |
Why?
|
| Robotics | 1 | 2011 | 272 | 0.280 |
Why?
|
| Prospective Studies | 4 | 2024 | 4825 | 0.260 |
Why?
|
| Creatinine | 2 | 2022 | 313 | 0.250 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2013 | 179 | 0.240 |
Why?
|
| Middle Aged | 12 | 2024 | 29442 | 0.240 |
Why?
|
| Treatment Outcome | 4 | 2022 | 9713 | 0.230 |
Why?
|
| Aged | 8 | 2024 | 21760 | 0.220 |
Why?
|
| Blood Transfusion | 2 | 2019 | 180 | 0.210 |
Why?
|
| Morphine Derivatives | 1 | 2022 | 8 | 0.190 |
Why?
|
| Brain Death | 1 | 2024 | 94 | 0.190 |
Why?
|
| Female | 10 | 2024 | 51570 | 0.180 |
Why?
|
| Heart Arrest, Induced | 1 | 2022 | 30 | 0.180 |
Why?
|
| Feasibility Studies | 1 | 2024 | 803 | 0.180 |
Why?
|
| Portal Vein | 1 | 2022 | 121 | 0.180 |
Why?
|
| Male | 13 | 2024 | 47109 | 0.180 |
Why?
|
| Injections, Spinal | 1 | 2021 | 49 | 0.170 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2012 | 192 | 0.170 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 7387 | 0.170 |
Why?
|
| Length of Stay | 2 | 2018 | 878 | 0.170 |
Why?
|
| Aorta | 1 | 2022 | 275 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 412 | 0.170 |
Why?
|
| Pulmonary Edema | 1 | 2021 | 56 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 1286 | 0.160 |
Why?
|
| Myxoma | 1 | 2020 | 28 | 0.160 |
Why?
|
| Embolism | 1 | 2020 | 32 | 0.160 |
Why?
|
| Arachnodactyly | 1 | 2020 | 2 | 0.160 |
Why?
|
| Stroke Volume | 1 | 2022 | 464 | 0.160 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 12 | 0.160 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 29 | 0.150 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 52 | 0.150 |
Why?
|
| Biomarkers | 2 | 2019 | 2022 | 0.150 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1783 | 0.150 |
Why?
|
| Craniosynostoses | 1 | 2020 | 76 | 0.140 |
Why?
|
| Glycation End Products, Advanced | 1 | 2018 | 12 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2022 | 234 | 0.140 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2018 | 21 | 0.140 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2018 | 25 | 0.140 |
Why?
|
| Echocardiography | 1 | 2022 | 783 | 0.140 |
Why?
|
| Retrospective Studies | 2 | 2024 | 10962 | 0.140 |
Why?
|
| Risk Factors | 3 | 2022 | 6232 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 208 | 0.130 |
Why?
|
| Spleen | 1 | 2018 | 375 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2018 | 45 | 0.130 |
Why?
|
| Electroencephalography | 1 | 2022 | 829 | 0.130 |
Why?
|
| Electric Stimulation | 1 | 2018 | 346 | 0.130 |
Why?
|
| Heart Failure, Diastolic | 1 | 2016 | 2 | 0.130 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2018 | 100 | 0.120 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 368 | 0.120 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 540 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2018 | 201 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 237 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2018 | 268 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2018 | 284 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 663 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2016 | 198 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2018 | 664 | 0.100 |
Why?
|
| Hypoxia | 1 | 2018 | 699 | 0.100 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 52 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 98 | 0.090 |
Why?
|
| Inflammation | 1 | 2019 | 1120 | 0.090 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2013 | 133 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 149 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 62 | 0.080 |
Why?
|
| Respiration, Artificial | 2 | 2011 | 462 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2012 | 142 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 101 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 91 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 360 | 0.080 |
Why?
|
| Hypertension | 1 | 2016 | 778 | 0.080 |
Why?
|
| Coronary Vessels | 1 | 2012 | 178 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 2011 | 156 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2012 | 391 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2012 | 489 | 0.070 |
Why?
|
| Acute Disease | 1 | 2011 | 860 | 0.070 |
Why?
|
| Adult | 4 | 2013 | 29564 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2011 | 541 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2011 | 357 | 0.070 |
Why?
|
| Logistic Models | 1 | 2011 | 1275 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2011 | 747 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2018 | 3621 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2011 | 520 | 0.060 |
Why?
|
| Chicago | 1 | 2011 | 1513 | 0.060 |
Why?
|
| Insulin | 1 | 2012 | 1227 | 0.060 |
Why?
|
| Mice | 1 | 2018 | 12697 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2011 | 2585 | 0.050 |
Why?
|
| Pregnancy | 1 | 2011 | 3244 | 0.050 |
Why?
|
| Time Factors | 1 | 2011 | 5576 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2022 | 76 | 0.050 |
Why?
|
| Stroke | 1 | 2011 | 1154 | 0.040 |
Why?
|
| Young Adult | 1 | 2013 | 7511 | 0.040 |
Why?
|
| Animals | 1 | 2018 | 28902 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 154 | 0.040 |
Why?
|
| Heart Atria | 1 | 2020 | 255 | 0.040 |
Why?
|
| Counterpulsation | 1 | 2018 | 21 | 0.030 |
Why?
|
| Reoperation | 1 | 2020 | 726 | 0.030 |
Why?
|
| Vitrectomy | 1 | 2016 | 48 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 3213 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2013 | 138 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 137 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 77 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2012 | 90 | 0.020 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2013 | 125 | 0.020 |
Why?
|
| Cardiology | 1 | 2013 | 124 | 0.020 |
Why?
|
| Cardioplegic Solutions | 1 | 2011 | 17 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2011 | 29 | 0.020 |
Why?
|
| Ischemia | 1 | 2013 | 262 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 2011 | 34 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 264 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2012 | 152 | 0.020 |
Why?
|
| Anesthesiology | 1 | 2013 | 171 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 282 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2011 | 161 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 237 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 236 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2013 | 315 | 0.020 |
Why?
|
| Anesthesia | 1 | 2011 | 174 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 527 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1784 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 707 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 483 | 0.020 |
Why?
|